Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

P3 Health Partners (PIII) Accounts Payables (2020 - 2025)

P3 Health Partners (PIII) has disclosed Accounts Payables for 5 consecutive years, with $14.4 million as the latest value for Q2 2025.

  • For the quarter ending Q2 2025, Accounts Payables changed N/A year-over-year to $14.4 million, compared with a TTM value of $14.4 million through Jun 2025, changed N/A, and an annual FY2024 reading of $8.4 million, changed N/A over the prior year.
  • Accounts Payables was $14.4 million for Q2 2025 at P3 Health Partners, up from $8.4 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $24.1 million in Q3 2022 and bottomed at $8.4 million in Q4 2024.
  • Average Accounts Payables over 4 years is $14.8 million, with a median of $11.6 million recorded in 2023.
  • Peak annual rise in Accounts Payables hit 51.69% in 2023, while the deepest fall reached 55.56% in 2023.
  • Year by year, Accounts Payables stood at $11.5 million in 2022, then increased by 0.76% to $11.6 million in 2023, then fell by 27.41% to $8.4 million in 2024, then skyrocketed by 70.52% to $14.4 million in 2025.
  • Business Quant data shows Accounts Payables for PIII at $14.4 million in Q2 2025, $8.4 million in Q4 2024, and $11.6 million in Q1 2024.